Issue Date | Title | Author(s) |
2022-12-01 | PCR263 What Does the EQ-5D-Y-5L Measure in Comparison to Other Generic Paediatric Health Related Quality of Life Instruments? | Bahrampour, M; Jones, R; Devlin, N; Dalziel, K; Mulhern, B |
2022-12-01 | PCR62 The Australian Paediatric Multi-Instrument Comparison (P-MIC) Study: Data Quality, Feasibility, Acceptability, and Construct Validity of the EQ-5D-Y-3L, EQ-5D-Y5L, CHU9D, PedsQL, HUI, PROMIS-25 and AQoL-6D | Jones, R; Mulhern, B; Devlin, N; O’Loughlin, R; Xiong, X; Bahrampour, M; McGregor, K; Yip, S; Hiscock, H; Dalziel, K |
2022-11-11 | Author Reply. | Brazier, J; Peasgood, T; Mukuria, C; Luo, N; Mulhern, B; Pickard, AS; Augustovski, F; Greiner, W; Engel, L |
2022-12-21 | Developing an Australian utility value set for MacNew-7D health states. | Kularatna, S; Chen, G; Norman, R; Mukuria, C; Rowen, D; Senanayake, S; Hettiarachchi, R; Mulhern, B; Fozzard, K; Parsonage, W; MacPhail, SM |
2022-12-01 | MSR68 Development of a Checklist for Studies Reporting the Elicitation of Stated Preferences Values for Child Health Related Quality of Life | Bailey, C; Howell, M; Raghunandan, R; Dalziel, K; Howard, K; Mulhern, B; Petrou, S; Rowen, D; Salisbury, A; Viney, R; Lancsar, E; Devlin, N |
2022-12-01 | HTA163 Development of SF-6Dv2 Health Utility Weights in the United States | Rendas-Baum, R; Mulhern, B; Thurn, C; McCausland, K; Brazier, J; Bjorner, J |
2022-11-01 | PSAT097 Patient Preference Research: Preferred Adjunctive Medication Attributes of Adult Patients with Classic Congenital Adrenal Hyperplasia | Manahan, R; Macey, J; Farrar, M; O’Donoghue, C; Knight, S; Carmichael, C; Marshall, C; Yonan, C; Imel, E; Salam, M; Mulhern, B |
2022-07 | PCR114 The Adjunctive Therapy Preferences of Adults with Classic Congenital Adrenal Hyperplasia: A Discrete Choice Experiment | Macey, J; Farrar, M; O’Donoghue, C; Knight, S; Carmichael, C; Marshall, C; Yonan, C; Imel, E; Salam, M; Mulhern, B |
2022-07 | PCR58 Participant Reinterpretation of Health States: A Think-Aloud Study of Decision-Making Strategies in Discrete Choice Experiments with the SF-6DV2 | Broderick, L; Lauher, M; White, M; Kosinski, M; Mulhern, B; Brazier, J; Bjorner, J |
2022-12-05 | What is measured by the composite, single-item pain/discomfort dimension of the EQ-5D-5L? An exploratory analysis. | Engel, L; Whitehurst, DGT; Haagsma, J; Janssen, MF; Mulhern, B |